Yodawy vs Chefaa

Chefaa is commonly described as free for patients to use, with revenue tied to pharmacy commissions, but that is a business model statement rather than a full consumer price list. Its Super Saving terms are publicly stated (examples include 15% off local medicines, a 700 EGP minimum order, and a 1 to 3 day window), yet delivery fees can vary by pharmacy and location. Because checkout totals can change with stock and partner-pharmacy pricing, predictability is moderate rather than high.

Yodawy’s app is free to download, and its Care Program advertises free delivery and no extra service charges, but it does not publish a universal program fee on the pages reviewed. For ordinary on-demand orders, a consistent official delivery-fee schedule is not clearly published, so users must rely on checkout totals. B2B PBM pricing is not public, which reduces price transparency for employers and insurers evaluating the service.

Chefaa publicly describes nearby-pharmacy ordering, prescription upload, pharmacist chat, medication reminders, scheduled orders, and tracking. A key differentiator is offering a fast delivery option (commonly marketed as up to 90 minutes) alongside a slower savings option tied to discounts. The feature set is broad for consumers, though the value depends on pharmacy stock accuracy in a given area.

Yodawy supports prescription upload, OTC additions, and pharmacy-fulfilled delivery, and it highlights chronic medication refills via the Care Program. It also references insurance-card and approval workflows, which can be important for insured users. Consumer-facing delivery options are present, but the strongest differentiation is the structured refill and care flow rather than shopping-style features.

Chefaa lists medication reminders and scheduled or recurring monthly orders as supported capabilities. Public references also mention a chronic-illness monthly package, but current pricing and full operating terms are not clearly verifiable from stable public pages. It likely works well for self-managed refills, but the depth of clinical-style coordination is less explicit.

Yodawy’s Care Program is explicitly positioned around monthly refills and delivering before a patient runs out, which directly targets adherence risk. The program also describes pharmacist support and corporate on-premise options, indicating a more structured service model for chronic care. Exact eligibility and program enrollment details can still vary, so users should confirm in-app.

Chefaa clearly connects consumers to licensed pharmacies and supports prescription workflows, but publicly accessible technical integration documentation (APIs, supported systems, implementation guides) is not established. That makes it harder for insurers or employers to evaluate integration effort upfront. Any B2B integration capability likely requires direct vendor confirmation.

Yodawy markets a Virtual Dispensary and PBM services, describing workflows that connect pharmacies, insurers, TPAs, providers, and corporates. This is clearer evidence of enterprise readiness than typical consumer-pharmacy apps. However, no public developer portal or API specification is consistently available, so integration scope and terms must be validated commercially.

Chefaa is evidenced as operating in Egypt; it has also been described as operating in Saudi Arabia, which does not expand its African footprint. Public information does not support multi-country African availability. For most Africa-based buyers, it should be treated as Egypt-only unless the company confirms otherwise.

Yodawy’s public materials indicate Egypt coverage, including a Care Program claim of presence across 38 cities and nationwide availability. There is no strong public evidence of operations outside Egypt in Africa. If you are outside Egypt, availability is the biggest constraint.

Chefaa’s Play Store rating has been reported around 4.4/5 with a large review count, suggesting many successful orders. At the same time, user feedback frequently mentions stock availability mismatches, cancellations, delivery delays, and price or delivery-fee changes near confirmation. Because fulfillment depends on partner pharmacies, outcomes can vary by area.

Yodawy’s App Store rating has been reported around 4.2 in some storefront snapshots, indicating generally positive usage. However, review summaries often cite late or incomplete orders, cancellations, limited delivery slots, and prescription or insurance approval issues. The additional insurance workflow steps can improve compliance, but may increase friction and failure points.

Chefaa markets an “ask a pharmacist” option and 24/7 availability, which is helpful for medication questions. User reviews still report slow responses or unresolved issues for order changes, refunds, and delivery problems, suggesting variability in support outcomes. Pharmacist availability is not the same as guaranteed rapid customer service for logistics issues.

Yodawy promotes pharmacist support, including 24-hour pharmacist availability in some Care Program materials. Yet user reviews frequently mention difficulty contacting customer service or getting issues resolved after delays or cancellations. For insurance-related cases, support responsiveness can be particularly important, but consistency is hard to verify publicly.